A daily pill, orforglipron, may help maintain weight loss for people transitioning from injectable therapies like Wegovy and Mounjaro, with 74.7%-79.3% of weight loss retained in a year, offering a cheaper alternative.
HealthAINHS England has approved mirvetuximab soravtansine (Elahere) for women with platinum-resistant ovarian cancer, marking the first new drug for this condition in over 20 years. The treatment, administered every three weeks, delayed cancer progression and prolonged survival by an average of four months in clinical trials.
HealthAIResearch suggests higher empathy scores in NHS hospitals correlate with improved patient safety, staff wellbeing, and reduced spending on agency staff. The study, which ranked trusts on empathy, found modest increases in scores linked to better CQC ratings and less burnout.
HealthAIA new issue of the American Journal of Public Health reveals how tobacco companies like Philip Morris and RJ Reynolds used strategies developed for selling cigarettes to market ultra-processed foods (UPFs), including Lunchables, to children. These strategies focused on optimizing formulations for rapid reward and creating addictive products. UPFs are linked to increased risks of dementia, cognitive decline, cardiovascular diseases, and certain cancers.
HealthAIPatrick McGonagle, 71, endured six years of constant pain waiting for a knee replacement in Northern Ireland. Despite strong painkillers, his mobility and quality of life were severely impacted. He finally received surgery after multiple cancellations, highlighting the strain on healthcare systems and the need for government funding.
HealthAIUK health secretary backs UKNSC recommendation against population-wide PSA screening, opting for targeted testing of high-risk BRCA2 mutation carriers. Funding is increased for the Transform trial to include more Black men, addressing concerns about health inequalities.
HealthAIMPs criticize NHS England for overloading GPs, leading to a failure to assess over-65s for fall risks. Only 17% of frail patients were assessed in 2024/25, despite falls being a major cause of death and costing the UK billions annually.
